MedTech

Five things for pharma marketers to know: Monday, May 4

Five things for pharma marketers to know: Monday, May 4

Drugmakers engage early with insurers; patients push for implant to be pulled from the market; about one-third of new drugs qualify for special approval pathways

Medtronic agrees to consent decree

The manufacturer's SynchroMed drug-infusion pump was associated with 14 deaths.

Editor's Desk: And the researchers go wild

Editor's Desk: And the researchers go wild

Apple's ResearchKit could accelerate the pace at which industry approaches start-ups building products in the patient-facing part of health tech

FDA approves Boston Scientific atrial fibrillation device

The approval follows three advisory panel reviews and a complete response letter.

Device maker pays feds $2.8M over physician false claims

Device maker pays feds $2.8M over physician false claims

Medtronic, as part of the settlement, will pay $602,000 to a whistleblower to settle charges it caused physicians to submit false claims to federal health programs.

Philips focuses on healthcare tech

Lightbulb company Royal Philips is swapping its heritage for the consumer healthcare business.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

GE buys interest in DNA

The finance, electric and broadcasting company has taken a $1-billion interest in DNA technology.

Covidien buys firm armed with missile tech

Covidien is buying ingestible-camera company Given Imaging.

Report: J&J nearing hip settlement

The current number is reported to hover around $4 billion.